We are live on ! Find out more
CC

Caxton Corporation Portfolio holdings

AUM $4.02M
1-Year Est. Return 256.08%
This Fund
S&P 500
This Quarter Est. Return
+35.69%
1 Year Est. Return
+256.08%
3 Year Est. Return
+777.99%
5 Year Est. Return
+744.68%
10 Year Est. Return
+18,621.85%
AUM
$108M
AUM Growth
+$25.3M
Cap. Flow
+$4.17M
Cap. Flow %
3.87%
Top 10 Hldgs %
93.85%
Holding
31
New
6
Increased
10
Reduced
5
Closed
5

Top Buys

Rank Stock Value
1
ABDC
Alcentra Capital Corp
ABDC
+$5.23M
2
KALA icon
KALA BIO
KALA
+$1.01M
3
GSM icon
FerroAtlántica
GSM
+$317K
4
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
+$210K
5
CACC icon
Credit Acceptance
CACC
+$198K

Top Sells

Rank Stock Value
1
ICMB icon
Investcorp Credit Management BDC
ICMB
+$1.3M
2
JBGS
JBG SMITH
JBGS
+$778K
3
ACRS icon
Aclaris Therapeutics
ACRS
+$453K
4
INDP icon
Indaptus Therapeutics
INDP
+$318K
5
ARCC icon
Ares Capital
ARCC
+$273K

Sector Composition

Rank Sector Weight
1 Healthcare 69.43%
2 Financials 8.02%
3 Materials 0.26%
4 Technology 0.23%
5 Consumer Discretionary 0.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SBBP
1
DELISTED
Strongbridge Biopharma plc.
SBBP
$32.9M 30.56%
6,612,065
+8,000
+0.1% +$39.4K
KALA icon
2
KALA BIO
KALA
$14.4M
$12.4M 11.52%
601
+57
+10% +$1.01M
LITS
3
Lite Strategy Inc
LITS
$33.6M
$10.6M 9.85%
172,956
– –
MTEM
4
DELISTED
Molecular Templates, Inc.
MTEM
$9.44M 8.76%
108,283
– –
GARS
5
DELISTED
Garrison Capital Inc.
GARS
$8.8M 8.16%
1,225,096
+7,374
+0.6% +$53.9K
SCYX icon
6
SCYNEXIS
SCYX
$42.4M
$6.53M 6.06%
54,063
– –
ICMB icon
7
Investcorp Credit Management BDC
ICMB
$12.3M
$6.32M 5.87%
862,670
-172,883
-17% -$1.3M
ABDC
8
DELISTED
Alcentra Capital Corp
ABDC
$6M 5.57%
800,000
+724,697
+962% +$5.23M
AMLP icon
9
Alerian MLP ETF
AMLP
$12.7B
$4.13M 3.83%
82,378
+3
+0% +$147
SPY icon
10
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$3.96M 3.67%
14,010
– –
BRK.B icon
11
Berkshire Hathaway Class B
BRK.B
$1.06T
$1.87M 1.74%
9,312
– –
ARQL
12
DELISTED
Arqule Inc
ARQL
$700K 0.65%
146,066
+21,631
+17% +$83.5K
EIGR
13
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$689K 0.64%
1,643
+186
+13% +$74.6K
VIRX
14
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$337K 0.31%
+7,921
New +$179K
KURA icon
15
Kura Oncology
KURA
$964M
$320K 0.3%
19,274
-13,554
-41% -$209K
CTIC
16
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$313K 0.29%
323,026
+199,085
+161% +$210K
GSM icon
17
FerroAtlántica
GSM
$626M
$285K 0.26%
+139,226
New +$317K
MRKR icon
18
Marker Therapeutics
MRKR
$21.8M
$280K 0.26%
4,237
-1,096
-21% -$64K
GB
19
DELISTED
Global Blue Group Holding
GB
$253K 0.23%
25,453
-1,663
-6% -$16.3K
FSTX
20
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$249K 0.23%
5,929
+670
+13% +$28.2K
FSK icon
21
FS KKR Capital
FSK
$3.06B
$245K 0.23%
10,115
-10,222
-50% -$253K
DRNA
22
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$230K 0.21%
15,727
+1,779
+13% +$20.4K
MELI icon
23
Mercado Libre
MELI
$92B
$221K 0.21%
+435
New +$173K
AMT icon
24
American Tower
AMT
$79.2B
$216K 0.2%
+1,097
New +$192K
CACC icon
25
Credit Acceptance
CACC
$6.69B
$208K 0.19%
+460
New +$198K
1
2

Similar funds

PCM
Pathway Capital Management Irvine, California $4.3M AUM 62.8% 1-Year Est. Return
EAMS
Eurizon Asset Management Slovakia Bratislava $3.4M AUM
RCP
RPM Capital Partners New York $3.34M AUM 43.17% 1-Year Est. Return
RA
Ritter Alpha New York $4.78M AUM
CGA
Compound Global Advisors Mercer Island, Washington $3.22M AUM 30.08% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
ABA
American Beacon Advisors Irving, Texas $5.08M AUM 20.11% 1-Year Est. Return
UOMF
University of Maryland Foundation Adelphi, Maryland $5.1M AUM 10.69% 1-Year Est. Return

Caxton Corporation's Q1 2019 Portfolio in Review

As of Q1 2019, Caxton Corporation held 31 positions worth $108M, up 31% from $82.4M the previous quarter. Its ten largest holdings account for 94% of the portfolio.

Caxton Corporation deployed $4.17M of net new capital in Q1 2019, opening 6 new positions and adding to 10 existing holdings. Its largest new stake was FerroAtlántica: 139,226 shares worth $285K.

By sector, the portfolio is most concentrated in Healthcare at 69% of assets, up from 69% a quarter earlier, followed by Financials and Materials.

On the sell side, the largest reduction was Investcorp Credit Management BDC, an estimated $1.3M trimmed.

  • Caxton Corporation's largest Q1 2019 buy was FerroAtlántica: 139,226 shares worth $285K.
  • Caxton Corporation added most to Alcentra Capital Corp in Q1 2019, an estimated $5.23M increase.
  • Caxton Corporation's biggest Q1 2019 reduction was Investcorp Credit Management BDC, cutting an estimated $1.3M.
  • Caxton Corporation fully exited JBG SMITH in Q1 2019, selling an estimated $778K.
  • Caxton Corporation's ten largest holdings make up 94% of its $108M portfolio in Q1 2019.
  • Caxton Corporation opened 6 new positions and closed 5 in Q1 2019.
  • Caxton Corporation's portfolio value rose 31% quarter-over-quarter to $108M.

Based on Caxton Corporation's 13F filing for Q1 2019, filed 14 May 2019.